2,346 research outputs found

    Effect of Ammonium Enrichment on Animal and Algal Biomass of the Coral Pocillopora damicornis

    Get PDF
    Algal and animal biomass parameters of colonies of the Pacific coral Pocillopora damicornis (Linnaeus) were measured as a function of time of exposure to elevated concentrations of seawater ammonium (20 and 50 uM [(NH4)2S04]) ranging from 2 to 8 weeks. Areal concentrations of zooxanthellae, chlorophyll, and protein increased with 20 uM ammonium addition. During the 8-week period of exposure to 20 uM ammonium, the population density of zooxanthellae increased from 3.5 to 7.5 x 105 cells cm-2, chlorophyll a content of zooxanthellae increased from 5.7 to 8.6 pg, and animal protein concentration doubled (from 0.74 to 1.38 mg cm-2). These data indicate that both the coral animal and the zooxanthellae respond to the addition of exogenous dissolved inorganic nitrogen provided as 20 uM ammonium. Growth of the symbiotic association in response to the addition of 20 uM ammonium adds further evidence to support the argument that growth of tropical symbioses is limited by the availability of nitrogen. However, the coral response is likely to depend on the concentration of ammonium provided, because the biomass parameters of corals held at 50 uM ammonium did not change significantly with time of exposure to the added nutrient

    DOT tomography of the solar atmosphere. IV. Magnetic patches in internetwork areas

    Full text link
    We use G-band and Ca II H image sequences from the Dutch Open Telescope (DOT) to study magnetic elements that appear as bright points in internetwork parts of the quiet solar photosphere and chromosphere. We find that many of these bright points appear recurrently with varying intensity and horizontal motion within longer-lived magnetic patches. We develop an algorithm for detection of the patches and find that all patches identified last much longer than the granulation. The patches outline cell patterns on mesogranular scales, indicating that magnetic flux tubes are advected by granular flows to mesogranular boundaries. Statistical analysis of the emergence and disappearance of the patches points to an average patch lifetime as long as 530+-50 min (about nine hours), which suggests that the magnetic elements constituting strong internetwork fields are not generated by a local turbulent dynamo.Comment: 8 pages, 6 figure

    Fine structure, magnetic field and heating of sunspot penumbrae

    Full text link
    We interpret penumbral filaments as due to convection in field-free, radially aligned gaps just below the visible surface of the penumbra, intruding into a nearly potential field above. This solves the classical discrepancy between the large heat flux and the low vertical velocities observed in the penumbra. The presence of the gaps causes strong small-scale fluctuations in inclination, azimuth angle and field strength, but without strong forces acting on the gas. The field is nearly horizontal in a region around the cusp-shaped top of the gap, thereby providing an environment for Evershed flows. We identify this region with the recently discovered dark penumbral cores. Its darkness has the same cause as the dark lanes in umbral light-bridges, reproduced in numerical simulations by Nordlund and Stein (2005). We predict that the large vertical and horizontal gradients of the magnetic field inclination and azimuth in the potential field model will produce the net circular polarization seen in observations. The model also explains the significant elevation of bright filaments above their surroundings. It predicts that dark areas in the penumbra are of two different kinds: dark filament cores containing the most inclined (horizontal) fields, and regions between bright filaments, containing the least inclined field lines.Comment: submitted to A&

    C60_{60} in intense femtosecond laser pulses: nonlinear dipole response and ionization

    Full text link
    We study the interaction of strong femtosecond laser pulses with the C60_{60} molecule employing time-dependent density functional theory with the ionic background treated in a jellium approximation. The laser intensities considered are below the threshold of strong fragmentation but too high for perturbative treatments such as linear response. The nonlinear response of the model to excitations by short pulses of frequencies up to 45eV is presented and analyzed with the help of Kohn-Sham orbital resolved dipole spectra. In femtosecond laser pulses of 800nm wavelength ionization is found to occur multiphoton-like rather than via excitation of a ``giant'' resonance.Comment: 14 pages, including 1 table, 5 figure

    Speciation, Luminescence, and Alkaline Fluorescence Quenching of 4-(2-methylbutyl)aminodipicolinic acid (H2MEBADPA)

    Get PDF
    4-(2-Methylbutyl)aminodipicolinic acid (H2MEBADPA) has been synthesized and fully characterized in terms of aqueous phase protonation constants (pKa\u27s) and photophysical measurements. The pKa\u27s were determined by spectrophotometric titrations, utilizing a fully sealed titration system. Photophysical measurements consisted of room temperature fluorescence and frozen solution phosphorescence as well as quantum yield determinations at various pH, which showed that only fully deprotonated MEBADPA2– is appreciably emissive. The fluorescence of MEBADPA2– has been determined to be quenched by hydroxide and methoxide anions, most likely through base-catalyzed excited-state tautomerism or proton transfer. This quenching phenomenon has been quantitatively explored through steady-state and time-resolved fluorescence measurements. Utilizing the determined pKas and quenching constants, the fluorescent intensity of MEBADPA2– has been successfully modeled as a function of pH

    Comments on entanglement entropy

    Get PDF
    A new interpretation of entanglement entropy is proposed: entanglement entropy of a pure state with respect to a division of a Hilbert space into two subspaces 1 and 2 is an amount of information, which can be transmitted through 1 and 2 from a system interacting with 1 to another system interacting with 2. The transmission medium is quantum entanglement between 1 and 2. In order to support the interpretation, suggestive arguments are given: variational principles in entanglement thermodynamics and quantum teleportation. It is shown that a quantum state having maximal entanglement entropy plays an important role in quantum teleportation. Hence, the entanglement entropy is, in some sense, an index of efficiency of quantum teleportation. Finally, implications for the information loss problem and Hawking radiation are discussed.Comment: Latex, 24 pages, proofs of some equations are added in appendices; Accepted for publication in Physical Review

    On Solving the Coronal Heating Problem

    Full text link
    This article assesses the current state of understanding of coronal heating, outlines the key elements of a comprehensive strategy for solving the problem, and warns of obstacles that must be overcome along the way.Comment: Accepted by Solar Physics; Published by Solar Physic

    Small-scale solar magnetic fields

    Get PDF
    As we resolve ever smaller structures in the solar atmosphere, it has become clear that magnetism is an important component of those small structures. Small-scale magnetism holds the key to many poorly understood facets of solar magnetism on all scales, such as the existence of a local dynamo, chromospheric heating, and flux emergence, to name a few. Here, we review our knowledge of small-scale photospheric fields, with particular emphasis on quiet-sun field, and discuss the implications of several results obtained recently using new instruments, as well as future prospects in this field of research.Comment: 43 pages, 18 figure

    Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

    Get PDF
    IMPORTANCE: Secretory phospholipase A2(sPLA2) generates bioactive phospholipid products implicated in atherosclerosis. The sPLA2inhibitor varespladib has favorable effects on lipid and inflammatory markers; however, its effect on cardiovascular outcomes is unknown. OBJECTIVE: To determine the effects of sPLA2inhibition with varespladib on cardiovascular outcomes. DESIGN, SETTING, AND PARTICIPANTS: A double-blind, randomized, multicenter trial at 362 academic and community hospitals in Europe, Australia, New Zealand, India, and North America of 5145 patients randomized within 96 hours of presentation of an acute coronary syndrome (ACS) to either varespladib (n = 2572) or placebo (n = 2573) with enrollment between June 1, 2010, and March 7, 2012 (study termination on March 9, 2012). INTERVENTIONS: Participants were randomized to receive varespladib (500 mg) or placebo daily for 16 weeks, in addition to atorvastatin and other established therapies. MAIN OUTCOMES AND MEASURES: The primary efficacy measurewas a composite of cardiovascular mortality, nonfatal myocardial infarction (MI), nonfatal stroke, or unstable angina with evidence of ischemia requiring hospitalization at 16 weeks. Six-month survival status was also evaluated. RESULTS: At a prespecified interim analysis, including 212 primary end point events, the independent data and safety monitoring board recommended termination of the trial for futility and possible harm. The primary end point occurred in 136 patients (6.1%) treated with varespladib compared with 109 patients (5.1%) treated with placebo (hazard ratio [HR], 1.25; 95%CI, 0.97-1.61; log-rank P = .08). Varespladib was associated with a greater risk of MI (78 [3.4%] vs 47 [2.2%]; HR, 1.66; 95%CI, 1.16-2.39; log-rank P = .005). The composite secondary end point of cardiovascular mortality, MI, and stroke was observed in 107 patients (4.6%) in the varespladib group and 79 patients (3.8%) in the placebo group (HR, 1.36; 95% CI, 1.02-1.82; P = .04). CONCLUSIONS AND RELEVANCE: In patients with recent ACS, varespladib did not reduce the risk of recurrent cardiovascular events and significantly increased the risk of MI. The sPLA2inhibition with varespladib may be harmful and is not a useful strategy to reduce adverse cardiovascular outcomes after ACS. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01130246. Copyright 2014 American Medical Association. All rights reserved
    • 

    corecore